SlideShare a Scribd company logo
??
BRAIN
STROKE
HEART
FAILURE,
Coronary
Heart
Disease
RETINOPATHY RENAL
FAILURE
1
 One in three adults worldwide, according to
the report, has raised blood pressure – a
condition that causes around half of all
deaths from stroke and heart disease.
 Overall prevalence for hypertension in India is
29.8%.
2
3
Presented by- Guided by-
Dr. Puneshwar Keshari Dr. Harini A.
P.G. IInd Year Associate Professor& HOD
Department of Dravya Guna
SDM College of Ayurveda & Hospital
Hassan
4
1. What is blood pressure?
2. Regulation of blood pressure
3. Parameters on which blood pressure depends
4. What is Hypertension?
5. Types of Hypertension
6. Classification of Blood Pressure
7. What is Antihypertensive?
8. Classification of Antihypertensive
9. Treatment of Hypertension
10. Antihypertensive models
11. Hypertension in Ayurveda
12. Research updates
13. Discussion
14. Conclusion
15. References
5
6
By definition, BP = CO X PVR
Physiologically, in both normal and hypertensive
individuals, blood pressure is maintained by
moment-to-moment regulation of cardiac
output and peripheral vascular resistance,
exerted at three anatomic sites: arterioles,
postcapillary venules (capacitance vessels), and
heart.
A fourth anatomic control site, the kidney,
contributes to maintenance of blood pressure
by regulating the volume of intravascular fluid.
7
 Baroreceptor reflex (aortic arch and carotid sinuses)
8
9
Cardiac output Total Peripheral Resistance
Stroke Volume And Heart Rate
SYSTOLIC BP DIASTOLIC BP
Preload can be defined as the initial stretching of the
cardiac myocytes prior to contraction (EDV)
Afterload is the load against which the heart has to
pump(TPR)
10
11
 Hypertension can be defined as:
A sustained rise in blood pressure.
It is a condition in which the arteries have
persistently high blood pressure, making harder
for the heart to pump blood in the vessels.
Basically it has 2 main components; the
SYSTOLIC and the DIASTOLIC blood pressure.
12
Types of
Hypertension
Essential Secondary
A disorder of unknown origin affecting the
Blood Pressure regulating mechanisms
Secondary to other disease processes
Environmental
Factors
Stress Na+ Intake Obesity Smoking
13
The JNC 7 (2003)- 7th Report of Joint National Committee(of
USA) on prevention, detection, evaluation and treatment of
high blood pressure,
Classified HTN as follows-
BP Classification Systolic BP in mm of
Hg
Diastolic BP in mm of
Hg
Normal < 120 < 80
Prehypertension 120- 139 80- 89
Hypertension Stage I 140 -159 90 - 99
Hypertension Stage II ≥ 160 ≥ 100
14
The drugs used in the
treatment of hypertension act
by reducing the cardiac
output and/or reducing the
total peripheral resistance,
without correcting the cause
15
16
4. Direct renin
inhibitor
Aliskiren
2.ACE inhibitors
Eg.
Captopril,
Enalapril,
Lisinopril etc.
3. Angiotensin (
AT1 receptor)
blockers
Eg. Losartan,
Candesartan etc.
1. Diuretics
Thiazides:
Hydroclorothiazide,
etc
High ceiling: Furosemide,
etc.
Potassium Sparing:
Spironolactone,
Amiloride
5. Calcium channel
blockers
Verapamil,
Diltiazem,
Nifedipine,
Lacidipine, etc.
6. Beta Adrenergic
blockers
Propranolol,
Metoprolol,
Atenolol, etc
17
 7. Beta+ alpha
Adrenergic
blockers
 Labetalol,
Carvedilol
8. Alpha Adrenergic
blockers
Prazosin, Terazosin,
Doxazosin etc.
9. Cenral
Sympatholytics
Clonidine,
Methyldopa
10. Vasodilators
Arteriolar :
Hydralazine, Minoxidil,
Diazoxide
Arteriolar + Venous :
Sodium nitroprusside
18
 MOA:
 1- ↑ renal excretion of Na & water
↓ plasma volume ↓ C.O.
 2- ↓ peripheral resistance ( desensitize smooth muscles
to action of catecholamine)
 Advantage: Effective in controlling blood pressure in
long term. Controls BP in Supine as well as standing
positions so postural hypotension doesn’t occur.
Disadvantage:
Of Thiazides include, hypokalemia, hyperuricemia;
Of Loop Diuretics include, Ototoxicity;
Of Potassium Sparing group include, Gastric upsets,
Gynecomastia in males, Menstrual irregularities in
females
19
20
MOA:
 ↓ ang II ↓ vasocostriction
 ↓ degradation of Bradykinin ( vasodilator)
21
Cough (dry Cough)
Angioedema
Proteinuria
Taste changes
Hypotension
Contraindicated in Pregnancy
Rashes
Increased K+ Levels
Low Ang II and Aldosterone levels
22
 Specific angiotensin receptors have been
discovered, grouped and abbreviated as –
AT1 and AT2
 They are present on the surface of the
target cells
 Most of the physiological actions of
angiotensin are mediated via AT1 receptor
 Losartan is the specific AT1 blocker
 Available as 25 and 50 mg tablets
23
 Upper respiratory infections
 Headache
 May cause occasional dizziness, inability to
sleep, diarrhea, dyspnea, heartburn, nasal
congestion, back pain, fatigue
24
 Aliskiren the only available member .
 Acts by blocking catalytic activity of renin and
inhibiting production of Ang I and Ang II.
 Second line antihypertensive when
established ACE inhibitors or ARBs cannot
be used, or to supplement them.
25
26
27
Calcium Channel Blockers
 Cardiovascular
◦ hypotension, palpitations, tachycardia
 Gastrointestinal
◦ constipation, nausea
 Other
◦ rash, flushing, peripheral edema, dermatitis
28
 Beta blockers :
Selectives: Metoprolol, Atenolol
Adverse Effect: Dizziness, Drowsiness,
Fatigue, Diarrhea
Non-Selectives: Propranolol
Adverse Effect: Drowsiness, Sedation,
Asthma
29
30
Acting on Alpha as well as on Beta receptors.
Labetolol, Carvidolol, Bucindolol
Adverse Effects: Drowsiness, Fatigue,
Insomnia, Orthostatic Hypotension
31
Selectives: Prazosine, terazosin
Adverse Effect: Orthostatic Hypotension
Non-Selectives: Phenoxybenzamine, Phentolamine
Adverse Effect: Tachycardia, Palpitation
Advantages- improvement in carbohydrate
metabolism, lowers LDL, increases HDL
Dose- available as 0.5, 1, 2.5 and 5 mg. 1-4 mg
TDS
32
33
 Directly relaxes arteriolar smooth muscle
 Result: decreased systemic vascular response,
decreased afterload, and
PERIPHERAL VASODILATION
 Eg.- Hydralazine (Hypertension in Pregnancy, Dose 25-
50 mg OD), Minoxidil, Sodium nitroprusside
 Adverse effects-
Hydralazine- Dizziness, Dyspnoea,
oedema etc.
Sodium nitroprusside- Bradycardia
34
??
35
36
 In the past, most studies
on experimental hypertension were carried
out on Dogs.
 Currently, rat is the preferred animal species
 Spontaneous hypertensive rat (SHR), the
genetic strain of hypertensive rat, is the
animal of choice
37
1.Renovascular hypertension
2. Dietary hypertension
3. Endocrine hypertension
4. Neurogenic hypertension
5. Psychogenic hypertension
6. Genetic hypertension
7. Other models
38
 GOLDBlAtT HYPERTENSION
Ischemia of kidney Blood pressure
RENIN ANGIOTENSIN MECHANISM
Clamping of Renal artery for 4 hours and reopening
Accumulated Renin is released
ACUTEHYPERTENSION
39
 Sprague – Dawley Rats (300gm) are anesthetized ĉ
Hexobarbital sodium (100mg/kg) Intra peritonially.
 Cannulate the trachea for respiration and the Jugular vein
for test compound administration.
 A transducer is connected to the carotid artery for
recording the pressure.
 A PVC coated clip is placed in the left hilum of the kidney
by fixing with the back muscle for 3.5 - 4hr.
 Pentolinium is administered for ganglionic block.
 Relaese the clip and record the rise in B.P.
 Administer the test drug through I.V. and monitor the
pressure continuously.
 Increase in B.P after releasing the clip and reduction after
the drug administration is determined.
 Compare using percentage values
40
 -Sprague – Dawley Rats (200 - 300gm) are anesthetized ĉ -
Phenobarbitone sodium (100mg/kg) Intra peritonially.
 -A flank parallel incision is made in the left lumbar area.
 -Renal artery is dissected, cleaned and ‘U’ shaped silver clip is
slipped around near the aorta.
 -The internal gap b/w the clip is adjusted to 0.25 – 0.38 nm.
 -The right kidney is removed after tying off the renal pedicel.
 -After 4-5 weeks the B.P is measured and the animals are
divided into groups of different doses.
 -Test drug is administered for 3 days
 -Pressure before and after drug administration(3min) are
recorded.
 -Percent reduction in pressure is calculated and compare to
the Std.
41
42
Hypertension in Ayurveda may fall under
Pittavruta udana(Su.S.Ni.1/35) Raktagata
vata(Ch.Chi. 28/31), Pittavruta vata,
Raktavruta vata, Pranavruta
udana, Rakta vega vridhi, Rasa bhara, Rakta
Samvardhana, Vyanabala,
Uccharaktachapa, Siragata vata,
Bhrama(Ch.su.20/10.Ma.Ni.17/1),
Raktamada(Ch.su. 24/34), Moorcha(Ma.Ni.17),
Sanyasa , Dhamanipratichaya,
Raktabhara Vridhi etc
43
44
Name of the Journal-
Pharmacogn.Rev. 2011Jan-June; 5(9): 30-40
Name of the Authors-
Nahida Tabassum and Feroz Ahmad
 Total 49 plants are reviewed for
Antihypertensive effect by experimental,
Clinical and Phytochemical evaluations
45
Agathosma betulina Cassia occidentalis Hibiscus sabdariffa Pueraria lobata
Allium sativum Castanospermum
australe
Lavandula stoechas Punica granatum
Annona muricata Coleus forskohlii Lepidium latifolium Raphanus sativus
Apium graveolens Commelina virginica Linum usitatissimum Rauwolfia serpentina
Aristolochia
manshuriensis
Crataegus pinnatifida Lumnitzera racemosa Rhaptopetalum
coriaceum oliver
Artocarpus altilis Crinum glaucum Lycopersicon
esculentum
Sesamum indicum
Avena sativa Cuscuta reflexa Moringa oleifera Solanum sisymbriifolium
Blond psyllium Daucus carota Musanga cecropiodes Theobroma cacao
Camellia sinensis Desmodium
styracifolium
Ocimum basilicum Triticum aestivum
Capparis cartilaginea Fuchsia magellanica Peganum harmala Uncaria rhynchophylla
Carum copticum Glycine max Phyllanthus amarus Viscum album
Cassia absus Gossypium
barbadense
Pinus pinaster Vitex doniana
Zingiber officinale46
1. Annona muricata
Hindi name – Lakshman phala
Family- Annonaceae
Parts used – fruit, leaves, bark
The leaf extract of the plant has been reported to lower an
elevated BP by decreasing the peripheral vascular resistance.
2. Apium graveolens
Family: Apiaceae
Sanskrit name- Ajmoda
Parts used - Fruit
The juice was mixed with equal amount of honey and about 8 ounces
were taken orally three times each day for up to one week. It has
also been reported to reduce systolic and diastolic BP.
47
3. Cassia occidentalis
Family- Caesalpiniaceae
Sanskrit name- Kasmarda
Parts used- Seeds, Panchanga
In vitro studies of the leaf extract have shown a relaxant effect on the
aortic rings. The studies revealed that cassia extract may be relaxing
smooth muscle and reducing BP by inhibiting Ca2+ influx through
receptor-operated channel and voltage-sensitive channel, showing
its nonselectivity on these Ca2+ channels.
4. Cuscuta reflexa
Family- Cuscutaceae
Sanskrit name- Amarvela
Parts used- whole plant
Crude extract of C. reflexa has been reported to cause a decrease in
systolic and diastolic BP as well as HR in anesthetized rats.
48
5. Moringa oleifera
Family- Moringaceae
Sanskrit name- Shigru
Parts used- Leaves, Fruit, Root
 In anesthetized rats, the crude extract of the leaves of
M. oleifera caused a fall in systolic, diastolic, and mean BP in a dose-
dependent manner.
6. Phyllanthus amarus
Family- Euphorbiaceae
Sanskrit name- Bhoomi Aamalki
Parts used- whole plant
intravenous administration of the aqueous extract of the leaves of this
plant (5-80 mg/kg) to anesthetized NMT male rabbits produced a
significant fall in mean diastolic, systolic, and mean arterial
pressures in a graded dose-response manner.
49
 Name of the Journal-
World journal of Pharmaceutical research, Vol.3(8): 769- 777
Name of Authors- V.Velpandian*, N.Anbu, S.Elangovan, M. Mohamed
Musthafa
Conclusion- Drug- Sadamanjil Chooranam (Nardostachys jatamansi)
Dose - 500mg and 1000mg/kg body weight
Route- Oral
Method of screening- 2 kidney 1 clipped, Gold Blatt
occlusion method
Result- statistically significant decrease in systolic and
diastolic blood pressure in renovascular hypertensive rat through
the action on renin angiotensin system.
50
 -The prevalence of Hypertension(HTN) is growing
on day by day.
 -Both Primary and Secondary HTNs are directly or
indirectly related with food habit, sedentary life
styles and consumption of various drugs.
 -The antihypertensive drugs are classified
according to their site of action, their target
receptors and their mode of actions.
 -Older drugs for Hypertension are outdated due
to their various adverse effects and newer are
going on to be incorporating in treatment
schedule.
51
 -All types of antihypertensive drugs are only
able to do symptomatic decrease in blood
pressure. They are not able to treat the real
cause of Hypertension.
 -Hypertension can be correlated with various
Vata and Raktagata vyadhi but the exact
terminology is not dealt in classical Ayurvedic
texts.
 -There are various herbs which are proven as
safe and better antihypertensive and search for
new one should be done on the basis of
scientifically proven and widely accepted
Screening models of Antihypertensive.
52
 Hypertension is becoming a global burden
and the world is looking towards natural
remedies system like Ayurveda, even though
there are various antihypertensive drugs in
contemporary system of medicine. So it is a
high time to adopt proper screening model of
antihypertensive and search for best solution
from herbs for HTN.
53
1. Tripathi. KD, Essential of Medical Pharmacology
2. Nahida Tabassum and Feroz Ahmad, Pharmacogn.Rev.
2011Jan-June; 5(9): 30-40
3. Dr.G.H.ANANTHASAYANA, MANAGEMENT OF ESSENTIAL
HYPERTENSION IN AYURVEDIC PERSPECTIVES, ( Desertation work
submitted to RGUHS)
4. D.K. BADYAL, H. LATA*, A.P. DADHICH, Indian Journal of Pharmacology
2003; 35: 349-362
5. V.Velpandian*, N.Anbu, S.Elangovan, M. Mohamed Musthafa, wjpr,
Vol.3(8): 769- 777
6. www.google searh.net.
54
55

More Related Content

What's hot

2013 ACC/AHA guidelines for blood cholesterol management
2013 ACC/AHA guidelines for blood cholesterol management2013 ACC/AHA guidelines for blood cholesterol management
2013 ACC/AHA guidelines for blood cholesterol management
Praveen Nagula
 
Empagliflozin and Cardiovascular Outcomes
Empagliflozin and Cardiovascular OutcomesEmpagliflozin and Cardiovascular Outcomes
Empagliflozin and Cardiovascular Outcomes
Uyen Nguyen
 
Eplerenone, a selective aldosterone blocker, in
Eplerenone, a selective aldosterone blocker, inEplerenone, a selective aldosterone blocker, in
Eplerenone, a selective aldosterone blocker, in
Salman Ahmed
 

What's hot (20)

Angina Management with Metabolic Agents
Angina Management with Metabolic AgentsAngina Management with Metabolic Agents
Angina Management with Metabolic Agents
 
overview of pharmacotherapy
overview of pharmacotherapyoverview of pharmacotherapy
overview of pharmacotherapy
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
Are all arbs the same?
Are all arbs the same?Are all arbs the same?
Are all arbs the same?
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatin
 
Recent advances in treatment of htn
Recent advances in treatment of htnRecent advances in treatment of htn
Recent advances in treatment of htn
 
Role of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic eventsRole of statin and clopidogrel in atherothrombotic events
Role of statin and clopidogrel in atherothrombotic events
 
2013 ACC/AHA guidelines for blood cholesterol management
2013 ACC/AHA guidelines for blood cholesterol management2013 ACC/AHA guidelines for blood cholesterol management
2013 ACC/AHA guidelines for blood cholesterol management
 
Dapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitorDapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitor
 
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada SelimEmpagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
 
Hypertension management for primary health care
Hypertension management for primary health careHypertension management for primary health care
Hypertension management for primary health care
 
Oral hypoglycaemic agents 2020
Oral hypoglycaemic agents 2020Oral hypoglycaemic agents 2020
Oral hypoglycaemic agents 2020
 
Empagliflozin and Cardiovascular Outcomes
Empagliflozin and Cardiovascular OutcomesEmpagliflozin and Cardiovascular Outcomes
Empagliflozin and Cardiovascular Outcomes
 
Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart Failure
 
Dyslipidemia approach
Dyslipidemia approachDyslipidemia approach
Dyslipidemia approach
 
Eplerenone, a selective aldosterone blocker, in
Eplerenone, a selective aldosterone blocker, inEplerenone, a selective aldosterone blocker, in
Eplerenone, a selective aldosterone blocker, in
 
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbahueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
Treatment of hypertension
Treatment of hypertensionTreatment of hypertension
Treatment of hypertension
 
SGLT-2
SGLT-2 SGLT-2
SGLT-2
 

Viewers also liked

DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
Prof Dr Bashir Ahmed Dar
 

Viewers also liked (20)

DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
DIABETES AND ITS COMPLICATIONS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...
 
ANALGESIC MODELS
ANALGESIC MODELSANALGESIC MODELS
ANALGESIC MODELS
 
The Factories Act 1948
The Factories Act 1948The Factories Act 1948
The Factories Act 1948
 
Analgesic models
Analgesic modelsAnalgesic models
Analgesic models
 
perpheral vascular disease & gangrene examination
perpheral vascular disease & gangrene examinationperpheral vascular disease & gangrene examination
perpheral vascular disease & gangrene examination
 
The Narcotics Control Act,1990
The Narcotics Control Act,1990 The Narcotics Control Act,1990
The Narcotics Control Act,1990
 
Acts related to addiction psychiatry
Acts related to addiction psychiatryActs related to addiction psychiatry
Acts related to addiction psychiatry
 
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
 
Indian Pharmacy act 1940 and 1945
Indian Pharmacy act 1940 and 1945Indian Pharmacy act 1940 and 1945
Indian Pharmacy act 1940 and 1945
 
Food Regulations, Safety & Quality Standards in India_2012
Food Regulations, Safety & Quality Standards in India_2012Food Regulations, Safety & Quality Standards in India_2012
Food Regulations, Safety & Quality Standards in India_2012
 
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
 
Cystic diseases of liver
Cystic diseases of liverCystic diseases of liver
Cystic diseases of liver
 
Overview of FSS Act, Rules & Regulation_2012
Overview of FSS Act, Rules & Regulation_2012Overview of FSS Act, Rules & Regulation_2012
Overview of FSS Act, Rules & Regulation_2012
 
drug and cosmetic act
drug and cosmetic actdrug and cosmetic act
drug and cosmetic act
 
Drugs and magic remedies act (objectionable advertisements) 1954
Drugs and magic remedies act (objectionable advertisements) 1954Drugs and magic remedies act (objectionable advertisements) 1954
Drugs and magic remedies act (objectionable advertisements) 1954
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Food Safety and Standard Authority of India
Food Safety and Standard Authority of IndiaFood Safety and Standard Authority of India
Food Safety and Standard Authority of India
 
Gangrene
GangreneGangrene
Gangrene
 
The pharmacy act
The pharmacy actThe pharmacy act
The pharmacy act
 
Dpco
DpcoDpco
Dpco
 

Similar to Anti hypertensive

Htn urgency and emg
Htn urgency and emgHtn urgency and emg
Htn urgency and emg
Sudhir Dev
 
pharmacotherapy of HTN.pdf
pharmacotherapy of HTN.pdfpharmacotherapy of HTN.pdf
pharmacotherapy of HTN.pdf
DerejeTsegaye8
 

Similar to Anti hypertensive (20)

Hypertenson and IHD
Hypertenson and IHDHypertenson and IHD
Hypertenson and IHD
 
2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdf2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdf
 
Hypertension according to latest clinical advances
Hypertension according to latest clinical advances Hypertension according to latest clinical advances
Hypertension according to latest clinical advances
 
Heart Failure (HF)
Heart Failure (HF)Heart Failure (HF)
Heart Failure (HF)
 
hypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacologyhypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacology
 
Management of Hypertension in Critical Illness
Management of Hypertension in Critical IllnessManagement of Hypertension in Critical Illness
Management of Hypertension in Critical Illness
 
2.6. HTN.pptx
2.6. HTN.pptx2.6. HTN.pptx
2.6. HTN.pptx
 
Anti hypertensive Drugs lecture for BAMS students
Anti hypertensive Drugs  lecture for BAMS studentsAnti hypertensive Drugs  lecture for BAMS students
Anti hypertensive Drugs lecture for BAMS students
 
Animal Models for anti-hypertensive Drugs
Animal Models for anti-hypertensive DrugsAnimal Models for anti-hypertensive Drugs
Animal Models for anti-hypertensive Drugs
 
Htn urgency and emg
Htn urgency and emgHtn urgency and emg
Htn urgency and emg
 
ANTIHYPERTENSIVES- MOA
ANTIHYPERTENSIVES- MOAANTIHYPERTENSIVES- MOA
ANTIHYPERTENSIVES- MOA
 
HTN ppt 333.ppt
HTN ppt 333.pptHTN ppt 333.ppt
HTN ppt 333.ppt
 
Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
 
Cardiovascular manik
Cardiovascular  manik Cardiovascular  manik
Cardiovascular manik
 
Pharmacology summary.pptx
Pharmacology summary.pptxPharmacology summary.pptx
Pharmacology summary.pptx
 
antihypertensive_agent
antihypertensive_agentantihypertensive_agent
antihypertensive_agent
 
Diagnóstico y manejo de los envenenamientos poco frecuentes
Diagnóstico y manejo de los envenenamientos poco frecuentesDiagnóstico y manejo de los envenenamientos poco frecuentes
Diagnóstico y manejo de los envenenamientos poco frecuentes
 
pharmacotherapy of HTN.pdf
pharmacotherapy of HTN.pdfpharmacotherapy of HTN.pdf
pharmacotherapy of HTN.pdf
 
Hypertesion & Anti-Hypertensive drugs
Hypertesion & Anti-Hypertensive drugsHypertesion & Anti-Hypertensive drugs
Hypertesion & Anti-Hypertensive drugs
 
Antihypertensives.pptx
Antihypertensives.pptxAntihypertensives.pptx
Antihypertensives.pptx
 

More from Puneshwar Keshari

More from Puneshwar Keshari (6)

AN EXPERIMENTAL EVALUATION OF RHODODENDRON ARBOREUM SM. AS ABHAVA PRATINIDH...
AN EXPERIMENTAL EVALUATION OF RHODODENDRON ARBOREUM  SM. AS ABHAVA  PRATINIDH...AN EXPERIMENTAL EVALUATION OF RHODODENDRON ARBOREUM  SM. AS ABHAVA  PRATINIDH...
AN EXPERIMENTAL EVALUATION OF RHODODENDRON ARBOREUM SM. AS ABHAVA PRATINIDH...
 
CRITICAL REVIEW OF PRAMEHAHARA DRAVYAS IN BHAVAPRAKASH NIGHANTU IN MANAGEMENT...
CRITICAL REVIEW OF PRAMEHAHARA DRAVYAS IN BHAVAPRAKASH NIGHANTU IN MANAGEMENT...CRITICAL REVIEW OF PRAMEHAHARA DRAVYAS IN BHAVAPRAKASH NIGHANTU IN MANAGEMENT...
CRITICAL REVIEW OF PRAMEHAHARA DRAVYAS IN BHAVAPRAKASH NIGHANTU IN MANAGEMENT...
 
Drugs used in yakrit vikara( liver diseses)
Drugs used in yakrit vikara( liver diseses)   Drugs used in yakrit vikara( liver diseses)
Drugs used in yakrit vikara( liver diseses)
 
Rasana controversy
Rasana controversyRasana controversy
Rasana controversy
 
Controversy, adulteration and substitution
Controversy, adulteration and substitutionControversy, adulteration and substitution
Controversy, adulteration and substitution
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 

Recently uploaded

Recently uploaded (20)

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 

Anti hypertensive

  • 2.  One in three adults worldwide, according to the report, has raised blood pressure – a condition that causes around half of all deaths from stroke and heart disease.  Overall prevalence for hypertension in India is 29.8%. 2
  • 3. 3
  • 4. Presented by- Guided by- Dr. Puneshwar Keshari Dr. Harini A. P.G. IInd Year Associate Professor& HOD Department of Dravya Guna SDM College of Ayurveda & Hospital Hassan 4
  • 5. 1. What is blood pressure? 2. Regulation of blood pressure 3. Parameters on which blood pressure depends 4. What is Hypertension? 5. Types of Hypertension 6. Classification of Blood Pressure 7. What is Antihypertensive? 8. Classification of Antihypertensive 9. Treatment of Hypertension 10. Antihypertensive models 11. Hypertension in Ayurveda 12. Research updates 13. Discussion 14. Conclusion 15. References 5
  • 6. 6
  • 7. By definition, BP = CO X PVR Physiologically, in both normal and hypertensive individuals, blood pressure is maintained by moment-to-moment regulation of cardiac output and peripheral vascular resistance, exerted at three anatomic sites: arterioles, postcapillary venules (capacitance vessels), and heart. A fourth anatomic control site, the kidney, contributes to maintenance of blood pressure by regulating the volume of intravascular fluid. 7
  • 8.  Baroreceptor reflex (aortic arch and carotid sinuses) 8
  • 9. 9
  • 10. Cardiac output Total Peripheral Resistance Stroke Volume And Heart Rate SYSTOLIC BP DIASTOLIC BP Preload can be defined as the initial stretching of the cardiac myocytes prior to contraction (EDV) Afterload is the load against which the heart has to pump(TPR) 10
  • 11. 11
  • 12.  Hypertension can be defined as: A sustained rise in blood pressure. It is a condition in which the arteries have persistently high blood pressure, making harder for the heart to pump blood in the vessels. Basically it has 2 main components; the SYSTOLIC and the DIASTOLIC blood pressure. 12
  • 13. Types of Hypertension Essential Secondary A disorder of unknown origin affecting the Blood Pressure regulating mechanisms Secondary to other disease processes Environmental Factors Stress Na+ Intake Obesity Smoking 13
  • 14. The JNC 7 (2003)- 7th Report of Joint National Committee(of USA) on prevention, detection, evaluation and treatment of high blood pressure, Classified HTN as follows- BP Classification Systolic BP in mm of Hg Diastolic BP in mm of Hg Normal < 120 < 80 Prehypertension 120- 139 80- 89 Hypertension Stage I 140 -159 90 - 99 Hypertension Stage II ≥ 160 ≥ 100 14
  • 15. The drugs used in the treatment of hypertension act by reducing the cardiac output and/or reducing the total peripheral resistance, without correcting the cause 15
  • 16. 16
  • 17. 4. Direct renin inhibitor Aliskiren 2.ACE inhibitors Eg. Captopril, Enalapril, Lisinopril etc. 3. Angiotensin ( AT1 receptor) blockers Eg. Losartan, Candesartan etc. 1. Diuretics Thiazides: Hydroclorothiazide, etc High ceiling: Furosemide, etc. Potassium Sparing: Spironolactone, Amiloride 5. Calcium channel blockers Verapamil, Diltiazem, Nifedipine, Lacidipine, etc. 6. Beta Adrenergic blockers Propranolol, Metoprolol, Atenolol, etc 17
  • 18.  7. Beta+ alpha Adrenergic blockers  Labetalol, Carvedilol 8. Alpha Adrenergic blockers Prazosin, Terazosin, Doxazosin etc. 9. Cenral Sympatholytics Clonidine, Methyldopa 10. Vasodilators Arteriolar : Hydralazine, Minoxidil, Diazoxide Arteriolar + Venous : Sodium nitroprusside 18
  • 19.  MOA:  1- ↑ renal excretion of Na & water ↓ plasma volume ↓ C.O.  2- ↓ peripheral resistance ( desensitize smooth muscles to action of catecholamine)  Advantage: Effective in controlling blood pressure in long term. Controls BP in Supine as well as standing positions so postural hypotension doesn’t occur. Disadvantage: Of Thiazides include, hypokalemia, hyperuricemia; Of Loop Diuretics include, Ototoxicity; Of Potassium Sparing group include, Gastric upsets, Gynecomastia in males, Menstrual irregularities in females 19
  • 20. 20
  • 21. MOA:  ↓ ang II ↓ vasocostriction  ↓ degradation of Bradykinin ( vasodilator) 21
  • 22. Cough (dry Cough) Angioedema Proteinuria Taste changes Hypotension Contraindicated in Pregnancy Rashes Increased K+ Levels Low Ang II and Aldosterone levels 22
  • 23.  Specific angiotensin receptors have been discovered, grouped and abbreviated as – AT1 and AT2  They are present on the surface of the target cells  Most of the physiological actions of angiotensin are mediated via AT1 receptor  Losartan is the specific AT1 blocker  Available as 25 and 50 mg tablets 23
  • 24.  Upper respiratory infections  Headache  May cause occasional dizziness, inability to sleep, diarrhea, dyspnea, heartburn, nasal congestion, back pain, fatigue 24
  • 25.  Aliskiren the only available member .  Acts by blocking catalytic activity of renin and inhibiting production of Ang I and Ang II.  Second line antihypertensive when established ACE inhibitors or ARBs cannot be used, or to supplement them. 25
  • 26. 26
  • 27. 27
  • 28. Calcium Channel Blockers  Cardiovascular ◦ hypotension, palpitations, tachycardia  Gastrointestinal ◦ constipation, nausea  Other ◦ rash, flushing, peripheral edema, dermatitis 28
  • 29.  Beta blockers : Selectives: Metoprolol, Atenolol Adverse Effect: Dizziness, Drowsiness, Fatigue, Diarrhea Non-Selectives: Propranolol Adverse Effect: Drowsiness, Sedation, Asthma 29
  • 30. 30
  • 31. Acting on Alpha as well as on Beta receptors. Labetolol, Carvidolol, Bucindolol Adverse Effects: Drowsiness, Fatigue, Insomnia, Orthostatic Hypotension 31
  • 32. Selectives: Prazosine, terazosin Adverse Effect: Orthostatic Hypotension Non-Selectives: Phenoxybenzamine, Phentolamine Adverse Effect: Tachycardia, Palpitation Advantages- improvement in carbohydrate metabolism, lowers LDL, increases HDL Dose- available as 0.5, 1, 2.5 and 5 mg. 1-4 mg TDS 32
  • 33. 33
  • 34.  Directly relaxes arteriolar smooth muscle  Result: decreased systemic vascular response, decreased afterload, and PERIPHERAL VASODILATION  Eg.- Hydralazine (Hypertension in Pregnancy, Dose 25- 50 mg OD), Minoxidil, Sodium nitroprusside  Adverse effects- Hydralazine- Dizziness, Dyspnoea, oedema etc. Sodium nitroprusside- Bradycardia 34
  • 35. ?? 35
  • 36. 36
  • 37.  In the past, most studies on experimental hypertension were carried out on Dogs.  Currently, rat is the preferred animal species  Spontaneous hypertensive rat (SHR), the genetic strain of hypertensive rat, is the animal of choice 37
  • 38. 1.Renovascular hypertension 2. Dietary hypertension 3. Endocrine hypertension 4. Neurogenic hypertension 5. Psychogenic hypertension 6. Genetic hypertension 7. Other models 38
  • 39.  GOLDBlAtT HYPERTENSION Ischemia of kidney Blood pressure RENIN ANGIOTENSIN MECHANISM Clamping of Renal artery for 4 hours and reopening Accumulated Renin is released ACUTEHYPERTENSION 39
  • 40.  Sprague – Dawley Rats (300gm) are anesthetized ĉ Hexobarbital sodium (100mg/kg) Intra peritonially.  Cannulate the trachea for respiration and the Jugular vein for test compound administration.  A transducer is connected to the carotid artery for recording the pressure.  A PVC coated clip is placed in the left hilum of the kidney by fixing with the back muscle for 3.5 - 4hr.  Pentolinium is administered for ganglionic block.  Relaese the clip and record the rise in B.P.  Administer the test drug through I.V. and monitor the pressure continuously.  Increase in B.P after releasing the clip and reduction after the drug administration is determined.  Compare using percentage values 40
  • 41.  -Sprague – Dawley Rats (200 - 300gm) are anesthetized ĉ - Phenobarbitone sodium (100mg/kg) Intra peritonially.  -A flank parallel incision is made in the left lumbar area.  -Renal artery is dissected, cleaned and ‘U’ shaped silver clip is slipped around near the aorta.  -The internal gap b/w the clip is adjusted to 0.25 – 0.38 nm.  -The right kidney is removed after tying off the renal pedicel.  -After 4-5 weeks the B.P is measured and the animals are divided into groups of different doses.  -Test drug is administered for 3 days  -Pressure before and after drug administration(3min) are recorded.  -Percent reduction in pressure is calculated and compare to the Std. 41
  • 42. 42
  • 43. Hypertension in Ayurveda may fall under Pittavruta udana(Su.S.Ni.1/35) Raktagata vata(Ch.Chi. 28/31), Pittavruta vata, Raktavruta vata, Pranavruta udana, Rakta vega vridhi, Rasa bhara, Rakta Samvardhana, Vyanabala, Uccharaktachapa, Siragata vata, Bhrama(Ch.su.20/10.Ma.Ni.17/1), Raktamada(Ch.su. 24/34), Moorcha(Ma.Ni.17), Sanyasa , Dhamanipratichaya, Raktabhara Vridhi etc 43
  • 44. 44
  • 45. Name of the Journal- Pharmacogn.Rev. 2011Jan-June; 5(9): 30-40 Name of the Authors- Nahida Tabassum and Feroz Ahmad  Total 49 plants are reviewed for Antihypertensive effect by experimental, Clinical and Phytochemical evaluations 45
  • 46. Agathosma betulina Cassia occidentalis Hibiscus sabdariffa Pueraria lobata Allium sativum Castanospermum australe Lavandula stoechas Punica granatum Annona muricata Coleus forskohlii Lepidium latifolium Raphanus sativus Apium graveolens Commelina virginica Linum usitatissimum Rauwolfia serpentina Aristolochia manshuriensis Crataegus pinnatifida Lumnitzera racemosa Rhaptopetalum coriaceum oliver Artocarpus altilis Crinum glaucum Lycopersicon esculentum Sesamum indicum Avena sativa Cuscuta reflexa Moringa oleifera Solanum sisymbriifolium Blond psyllium Daucus carota Musanga cecropiodes Theobroma cacao Camellia sinensis Desmodium styracifolium Ocimum basilicum Triticum aestivum Capparis cartilaginea Fuchsia magellanica Peganum harmala Uncaria rhynchophylla Carum copticum Glycine max Phyllanthus amarus Viscum album Cassia absus Gossypium barbadense Pinus pinaster Vitex doniana Zingiber officinale46
  • 47. 1. Annona muricata Hindi name – Lakshman phala Family- Annonaceae Parts used – fruit, leaves, bark The leaf extract of the plant has been reported to lower an elevated BP by decreasing the peripheral vascular resistance. 2. Apium graveolens Family: Apiaceae Sanskrit name- Ajmoda Parts used - Fruit The juice was mixed with equal amount of honey and about 8 ounces were taken orally three times each day for up to one week. It has also been reported to reduce systolic and diastolic BP. 47
  • 48. 3. Cassia occidentalis Family- Caesalpiniaceae Sanskrit name- Kasmarda Parts used- Seeds, Panchanga In vitro studies of the leaf extract have shown a relaxant effect on the aortic rings. The studies revealed that cassia extract may be relaxing smooth muscle and reducing BP by inhibiting Ca2+ influx through receptor-operated channel and voltage-sensitive channel, showing its nonselectivity on these Ca2+ channels. 4. Cuscuta reflexa Family- Cuscutaceae Sanskrit name- Amarvela Parts used- whole plant Crude extract of C. reflexa has been reported to cause a decrease in systolic and diastolic BP as well as HR in anesthetized rats. 48
  • 49. 5. Moringa oleifera Family- Moringaceae Sanskrit name- Shigru Parts used- Leaves, Fruit, Root  In anesthetized rats, the crude extract of the leaves of M. oleifera caused a fall in systolic, diastolic, and mean BP in a dose- dependent manner. 6. Phyllanthus amarus Family- Euphorbiaceae Sanskrit name- Bhoomi Aamalki Parts used- whole plant intravenous administration of the aqueous extract of the leaves of this plant (5-80 mg/kg) to anesthetized NMT male rabbits produced a significant fall in mean diastolic, systolic, and mean arterial pressures in a graded dose-response manner. 49
  • 50.  Name of the Journal- World journal of Pharmaceutical research, Vol.3(8): 769- 777 Name of Authors- V.Velpandian*, N.Anbu, S.Elangovan, M. Mohamed Musthafa Conclusion- Drug- Sadamanjil Chooranam (Nardostachys jatamansi) Dose - 500mg and 1000mg/kg body weight Route- Oral Method of screening- 2 kidney 1 clipped, Gold Blatt occlusion method Result- statistically significant decrease in systolic and diastolic blood pressure in renovascular hypertensive rat through the action on renin angiotensin system. 50
  • 51.  -The prevalence of Hypertension(HTN) is growing on day by day.  -Both Primary and Secondary HTNs are directly or indirectly related with food habit, sedentary life styles and consumption of various drugs.  -The antihypertensive drugs are classified according to their site of action, their target receptors and their mode of actions.  -Older drugs for Hypertension are outdated due to their various adverse effects and newer are going on to be incorporating in treatment schedule. 51
  • 52.  -All types of antihypertensive drugs are only able to do symptomatic decrease in blood pressure. They are not able to treat the real cause of Hypertension.  -Hypertension can be correlated with various Vata and Raktagata vyadhi but the exact terminology is not dealt in classical Ayurvedic texts.  -There are various herbs which are proven as safe and better antihypertensive and search for new one should be done on the basis of scientifically proven and widely accepted Screening models of Antihypertensive. 52
  • 53.  Hypertension is becoming a global burden and the world is looking towards natural remedies system like Ayurveda, even though there are various antihypertensive drugs in contemporary system of medicine. So it is a high time to adopt proper screening model of antihypertensive and search for best solution from herbs for HTN. 53
  • 54. 1. Tripathi. KD, Essential of Medical Pharmacology 2. Nahida Tabassum and Feroz Ahmad, Pharmacogn.Rev. 2011Jan-June; 5(9): 30-40 3. Dr.G.H.ANANTHASAYANA, MANAGEMENT OF ESSENTIAL HYPERTENSION IN AYURVEDIC PERSPECTIVES, ( Desertation work submitted to RGUHS) 4. D.K. BADYAL, H. LATA*, A.P. DADHICH, Indian Journal of Pharmacology 2003; 35: 349-362 5. V.Velpandian*, N.Anbu, S.Elangovan, M. Mohamed Musthafa, wjpr, Vol.3(8): 769- 777 6. www.google searh.net. 54
  • 55. 55

Editor's Notes

  1. EDV- E CHOCARDIOGRAPHICALLY VOLUMETRIC MEASUREMENT, TPR- total peripheral resistance.
  2. Labetolol- 200 -400 mg, Carvidolol 3.125 mg, Bucindolol is labetolol used as iv…not more than 300 mg perday..
  3. NTS- Nucleus Tractus solitarius ( receives input from peripheral baroreceptors cells), RVLM- ROSTROVENTROLATERAL MEDULLA